Alzheimer’s disease is a neurodegenerative disorder that manifests with the deterioration of brain functions, such as memory, language, judgment, and reasoning – to a point of complete immobility – has made this condition a daunting diagnosis to receive. As of 2022,have dementia or dementia-related diseases.
Up until the last few years, there was no viable therapeutic to minimize the progression of early onset Alzheimer’s disease.Leqembi , a promising new treatment that has shown to lessen the progression of Alzheimer’s disease in its early stages., another drug that works to lessen symptoms of mild cognitive impairment, is expected to be fully approved in the following months. Both drugs are undoubtedly a significant advancement in the fight against a devastating disease.